We are live on ! Find out more
LYRA

LYRA THERAPEUTICS INC

Delisted

LYRA was delisted on the 16th of March, 2026.

33 hedge funds and large institutions have $22.4M invested in LYRA THERAPEUTICS INC in 2021 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 11 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.24% less ownership

Funds ownership: 1.03%0.79% (-0.24%)

6% less funds holding

Funds holding: 3533 (-2)

13% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 8

45% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 11

63% less capital invested

Capital invested by funds: $60.8M → $22.4M (-$38.5M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
33
Holders Change
-2
Holders Change %
-5.71%
% of All Funds
0.51%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
7
Increased
6
Reduced
11
Closed
8
Calls
Puts
Net Calls
Net Calls Change

LYRA Hedge Fund Activity: Q4 2021 in Review

33 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in LYRA THERAPEUTICS INC (LYRA) for Q4 2021, worth a combined $22.4M — down 63% from $60.8M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of LYRA and 7 opened new positions — a net loss of 1 holder — while 11 trimmed existing stakes and 6 added.

The largest buyer was Clearline Capital, opening a new position worth an estimated $417K. The largest seller was Soleus Capital Management, cutting an estimated $1.32M.

  • 33 institutional investors held LYRA THERAPEUTICS INC (LYRA) as of Q4 2021, down from 35 in Q3 2021.
  • Funds reported $22.4M of LYRA THERAPEUTICS INC stock for Q4 2021, down 63% quarter-over-quarter.
  • 7 funds opened new LYRA THERAPEUTICS INC positions in Q4 2021 and 8 closed out, a net change of -1 holder.
  • The largest LYRA THERAPEUTICS INC buyer in Q4 2021 was Clearline Capital, an estimated $417K added.
  • The largest LYRA THERAPEUTICS INC seller in Q4 2021 was Soleus Capital Management, an estimated $1.32M sold.

Based on aggregated 13F filings for Q4 2021.